The limits of molecular signatures for pancreatic ductal adenocarcinoma subtyping

Molecular signatures have been suggested as biomarkers to classify pancreatic ductal adenocarcinoma (PDAC) into two, three, four or five subtypes. Since the robustness of existing signatures is controversial, we performed a systematic evaluation of four established signatures for PDAC stratification...

Descripción completa

Detalles Bibliográficos
Autores principales: Lautizi, Manuela, Baumbach, Jan, Weichert, Wilko, Steiger, Katja, List, Markus, Pfarr, Nicole, Kacprowski, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Cancer Computational Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575186/
https://www.ncbi.nlm.nih.gov/pubmed/36267208
http://dx.doi.org/10.1093/narcan/zcac030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575186/
https://www.ncbi.nlm.nih.gov/pubmed/36267208
http://dx.doi.org/10.1093/narcan/zcac030

Ejemplares similares